SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 69 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

Application WO-2021078912-A1

World Intellectual Property Organisation (WIPO)